Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Circulating microRNAs as Potential Biomarkers of Infectious Disease.

Correia CN, Nalpas NC, McLoughlin KE, Browne JA, Gordon SV, MacHugh DE, Shaughnessy RG.

Front Immunol. 2017 Feb 16;8:118. doi: 10.3389/fimmu.2017.00118. eCollection 2017. Review.

2.

B-Cell-Based and Soluble Biomarkers in Body Liquids for Predicting Acute/Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

Juric MK, Shevtsov M, Mozes P, Ogonek J, Crossland RE, Dickinson AM, Greinix HT, Holler E, Weissinger EM, Multhoff G.

Front Immunol. 2017 Jan 16;7:660. doi: 10.3389/fimmu.2016.00660. eCollection 2016. Review.

3.

Contact Transfer Printing of Side Edge Prefunctionalized Nanoplasmonic Arrays for Flexible microRNA Biosensor.

Lee J, Park J, Lee JY, Yeo JS.

Adv Sci (Weinh). 2015 Jun 24;2(9):1500121. eCollection 2015 Sep.

4.

MicroRNAs in Coronary Heart Disease: Ready to Enter the Clinical Arena?

Cavarretta E, Frati G.

Biomed Res Int. 2016;2016:2150763. Epub 2016 Nov 2. Review.

5.

Optimized Collection Protocol for Plasma MicroRNA Measurement in Patients with Cardiovascular Disease.

Wu CS, Lin FC, Chen SJ, Chen YL, Chung WJ, Cheng CI.

Biomed Res Int. 2016;2016:2901938. Epub 2016 Sep 20.

6.

Identification of extracellular miRNA in archived serum samples by next-generation sequencing from RNA extracted using multiple methods.

Gautam A, Kumar R, Dimitrov G, Hoke A, Hammamieh R, Jett M.

Mol Biol Rep. 2016 Oct;43(10):1165-78. doi: 10.1007/s11033-016-4043-6. Epub 2016 Aug 10.

7.

Heparinase treatment of heparin-contaminated plasma from coronary artery bypass grafting patients enables reliable quantification of microRNAs.

Kondratov K, Kurapeev D, Popov M, Sidorova M, Minasian S, Galagudza M, Kostareva A, Fedorov A.

Biomol Detect Quantif. 2016 Apr 8;8:9-14. doi: 10.1016/j.bdq.2016.03.001. eCollection 2016 Jun.

8.

Proposal of supervised data analysis strategy of plasma miRNAs from hybridisation array data with an application to assess hemolysis-related deregulation.

Landoni E, Miceli R, Callari M, Tiberio P, Appierto V, Angeloni V, Mariani L, Daidone MG.

BMC Bioinformatics. 2015 Nov 18;16:388. doi: 10.1186/s12859-015-0820-9.

9.

Prognostic Role of MicroRNA-200c-141 Cluster in Various Human Solid Malignant Neoplasms.

Li XY, Li H, Bu J, Xiong L, Guo HB, Liu LH, Xiao T.

Dis Markers. 2015;2015:935626. doi: 10.1155/2015/935626. Epub 2015 Oct 18. Review.

10.

Circulating microRNA Biomarkers as Liquid Biopsy for Cancer Patients: Pros and Cons of Current Assays.

Ono S, Lam S, Nagahara M, Hoon DS.

J Clin Med. 2015 Oct 23;4(10):1890-907. doi: 10.3390/jcm4101890. Review. Erratum in: J Clin Med. 2016;5(9). pii: E81. doi: 10.3390/jcm5090081.

11.

Data Normalization Strategies for MicroRNA Quantification.

Schwarzenbach H, da Silva AM, Calin G, Pantel K.

Clin Chem. 2015 Nov;61(11):1333-42. doi: 10.1373/clinchem.2015.239459. Epub 2015 Sep 25. Review.

12.

Normalization of circulating microRNA expression data obtained by quantitative real-time RT-PCR.

Marabita F, de Candia P, Torri A, Tegnér J, Abrignani S, Rossi RL.

Brief Bioinform. 2016 Mar;17(2):204-12. doi: 10.1093/bib/bbv056. Epub 2015 Aug 3.

13.

Circulating DNA and Micro-RNA in Patients with Pancreatic Cancer.

Vietsch EE, van Eijck CH, Wellstein A.

Pancreat Disord Ther. 2015 Jun;5(2). pii: 156.

14.

Circulating MicroRNA-21 Is a Potential Diagnostic Biomarker in Gastric Cancer.

Wu J, Li G, Wang Z, Yao Y, Chen R, Pu X, Wang J.

Dis Markers. 2015;2015:435656. doi: 10.1155/2015/435656. Epub 2015 May 3.

15.

Challenges in using circulating miRNAs as cancer biomarkers.

Tiberio P, Callari M, Angeloni V, Daidone MG, Appierto V.

Biomed Res Int. 2015;2015:731479. doi: 10.1155/2015/731479. Epub 2015 Mar 22. Review.

16.

Optimized microRNA purification from TRIzol-treated plasma.

Duy J, Koehler JW, Honko AN, Minogue TD.

BMC Genomics. 2015 Feb 18;16:95. doi: 10.1186/s12864-015-1299-5.

17.
18.

Circulating RNA molecules as biomarkers in liver disease.

Enache LS, Enache EL, Ramière C, Diaz O, Bancu L, Sin A, André P.

Int J Mol Sci. 2014 Sep 30;15(10):17644-66. doi: 10.3390/ijms151017644. Review.

19.

Prognostic role of microRNA-145 in various human malignant neoplasms: a meta-analysis of 18 related studies.

Yang J, Zhang JY, Chen J, Chen C, Song XM, Xu Y, Li J.

World J Surg Oncol. 2014 Aug 9;12:254. doi: 10.1186/1477-7819-12-254.

20.

Circulating microRNA testing for the early diagnosis and follow-up of colorectal cancer patients.

Fesler A, Jiang J, Zhai H, Ju J.

Mol Diagn Ther. 2014 Jun;18(3):303-8. doi: 10.1007/s40291-014-0089-0. Review.

Supplemental Content

Support Center